参考文献/References:
[1] Birnie DH,Tang AS. The problem of non-response to cardiac resynchronization therapy[J]. Curr Opin Cardiol,2006,21(1):20-26.
[2] Boidol J,?redniawa B,Kowalski O,et al. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy:validation using data from the randomized trial[J]. Europace,2013,15(6): 835-844.
[3] Gold MR,Rickard J,Daubert JC,et al. Association of left ventricular remodeling with cardiac resynchronization therapy outcomes[J]. Heart Rhythm,2023,20(2):173-180.
[4] Linde C,Cleland JGF,Gold MR,et al. The interaction of sex,height,and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality:an individual-patient data meta-analysis[J]. Eur J Heart Fail,2018,20(4):780-791.
[5] Gasparini M,Galimberti P. Atrial fibrillation and cardiac resynchronization therapy[J]. Curr Opin Cardiol,2018,33(1):1-6.
[6] Tolosana JM,Hernandez Madrid A,Brugada J,et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] study)[J]. Am J Cardiol,2008,102(4):444-449.
[7] Dalgaard F,Fudim M,Al-Khatib SM,et al. Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation:insights from four major clinical trials[J]. J Cardiovasc Electrophysiol,2023,34(9):1914-1924.
[8] Boriani G,Gasparini M,Landolina M,et al. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy[J]. Eur J Heart Fail,2011,13(8):868-876.
[9] Jacobsson J,Reitan C,Carlson J,et al. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy[J]. BMC Cardiovasc Disord,2019,19(1):195.
[10] Dei Cas A,Khan SS,Butler J,et al. Impact of diabetes on epidemiology,treatment,and outcomes of patients with heart failure[J]. JACC Heart Fail,2015,3(2):136-145.
[11] Tan ESJ,Lim J,Chan SP,et al. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study)[J]. Am J Cardiol,2019,124(6):899-906.
[12] Kahr PC,Trenson S,Schindler M,et al. Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus:a long-term retrospective cohort study[J]. ESC Heart Fail,2020,7(5):2773-2783.
[13] Shah RV,Altman RK,Park MY,et al. Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure[J]. Am J Cardiol,2012,110(5):683-688.
[14] Zeitler EP,Friedman DJ,Daubert JP,et al. Multiple comorbidities and response to cardiac resynchronization therapy:MADIT-CRT long-term follow-up[J]. J Am Coll Cardiol,2017,69(19):2369-2379.
[15] Fudim M,Dalgaard F,Friedman DJ,et al. Comorbidities and clinical response to cardiac resynchronization therapy:patient-level meta-analysis from eight clinical trials[J]. Eur J Heart Fail,2024,26(4):1039-1046.
[16] Strauss DG,Selvester RH,Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy[J]. Am J Cardiol,2011,107(6):927-934.
[17] Hadjis A,Alturki A,Proietti R,et al. Predicting response to cardiac resynchronization therapy:use of strict left bundle branch block criteria[J]. Pacing Clin Electrophysiol,2019,42(4):431-438.
[18] García-Seara J,Iglesias Alvarez D,Alvarez Alvarez B,et al. Cardiac resynchronization therapy response in heart failure patients with different subtypes of true left bundle branch block[J]. J Interv Card Electrophysiol,2018,52(1):91-101.
[19] Pietrasik G,Zar?ba W. QRS fragmentation:diagnostic and prognostic significance[J]. Cardiol J,2012,19(2):114-121.
[20] 穆耶赛尔·玉苏普,董震宇,芦颜美,等. 碎裂QRS波与心脏再同步化治疗无反应的关系:荟萃分析[J]. 临床心血管病杂志,2023,39(3):220-225.
[21] Celikyurt U,Karauzum K,Sahin T,et al. Association between resolution of fragmented QRS and response to cardiac resynchronization therapy[J]. Ann Noninvasive Electrocardiol,2015,20(2):126-131.
[22] Celikyurt U,Agacdiken A,Sahin T,et al. Number of leads with fragmented QRS predicts response to cardiac resynchronization therapy[J]. Clin Cardiol,2013,36(1):36-39.
[23] Aalen JM,Donal E,Larsen CK,et al. Imaging predictors of response to cardiac resynchronization therapy:left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance[J]. Eur Heart J,2020,41(39):3813-3823.
[24] Fernández-Armenta J,Berruezo A,Mont L,et al. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy[J]. Europace,2012,14(11):1578-1586.
[25] 陈中丽,马璇,徐楠,等. 基于磁共振的室间隔应变对不符合真性左束支阻滞患者心脏再同步治疗反应的预测价值[J]. 中华心律失常学杂志,2023,27(5):397-405.
[26] Bilchick KC,Auger DA,Abdishektaei M,et al. CMR DENSE and the Seattle Heart Failure Model inform survival and arrhythmia risk after CRT[J]. JACC Cardiovasc Imaging,2020,13(4):924-936.
[27] Yu CM,Fung WH,Lin H,et al. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy[J]. Am J Cardiol,2003,91(6):684-688.
[28] Chung ES,Leon AR,Tavazzi L,et al. Results of the predictors of response to CRT (PROSPECT) trial[J]. Circulation,2008,117(20):2608-2616.
[29] Bertini M,Ng ACT,Antoni ML,et al. Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy[J]. Circ Cardiovasc Imaging,2012,5(3):383-391.
[30] Cameli M,Mondillo S,Righini FM,et al. Left ventricular deformation and myocardial fibrosis in patients with advanced heart failure requiring transplantation[J]. J Card Fail,2016,22(11):901-907.
[31] Khidir MJH,Abou R,Yilmaz D,et al. Prognostic value of global longitudinal strain in heart failure patients treated with cardiac resynchronization therapy[J]. Heart Rhythm,2018,15(10):1533-1539.
[32] Bazoukis G,Thomopoulos C,Tse G,et al. Global longitudinal strain predicts responders after cardiac resynchronization therapy—A systematic review and meta-analysis[J]. Heart Fail Rev,2022,27(3):827-836.
[33] Heggermont W,Auricchio A,Vanderheyden M. Biomarkers to predict the response to cardiac resynchronization therapy[J]. Europace,2019,21(11):1609-1620.?
[34] Goldenberg I,Moss AJ,Hall WJ,et al. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy(MADIT-CRT)[J]. Circulation,2011,124(14):1527-1536.
[35] Manlucu J,Sharma V,Koehler J,et al. Incremental value of implantable cardiac device diagnostic variables over clinical parameters to predict mortality in patients with mild to moderate heart failure[J]. J Am Heart Assoc,2019,8(14):e010998.
[36] Tokodi M,Schwertner WR,Kovács A,et al. Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy:the SEMMELWEIS-CRT score[J]. Eur Heart J,2020,41(18):1747-1756.
[37] Spinale FG,Meyer TE,Stolen CM,et al. Development of a biomarker panel to predict cardiac resynchronization therapy response:results from the SMART-AV trial[J]. Heart Rhythm,2019,16(5):743-753.
[38] Liang Y,Ding R,Wang J,et al. Prediction of response after cardiac resynchronization therapy with machine learning[J]. Int J Cardiol,2021,344:120-126.
[39] Maille B,Bodin A,Bisson A,et al. Predicting outcome after cardiac resynchronisation therapy defibrillator implantation:the cardiac resynchronisation therapy defibrillator Futility score[J]. Heart,2022,108(15):1186-1193.
[40] Wouters PC,van de Leur RR,Vessies MB,et al. Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy[J]. Eur Heart J,2023,44(8):680-692.
[41] Nazar W,Szymanowicz S,Nazar K,et al. Artificial intelligence models in prediction of response to cardiac resynchronization therapy:a systematic review[J]. Heart Fail Rev,2024,29(1):133-150.
相似文献/References:
[1]黄晓凤 熊峰.超声心动图技术在优化心脏再同步化治疗效果中的应用[J].心血管病学进展,2019,(7):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
HUANG XiaofengXIONG Feng.Application of Echocardiography in Optimizing Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2019,(3):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
[2]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J].心血管病学进展,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
HU Wei,SU Fangju,ZHANG Weize.Application of Left Ventricular Quadrupole in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
[3]熊倩 俞杉.心肌应变成像在CRT评估中的研究进展[J].心血管病学进展,2020,(4):399.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.018]
XIONG QianYU Shan.Myocardial Strain Imaging in C Assessment[J].Advances in Cardiovascular Diseases,2020,(3):399.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.018]
[4]林杰 李海瑞 李海鹰.左束支区域起搏的现状和展望[J].心血管病学进展,2020,(5):462.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.006]
LIN Jie,LI Hairui,LI Haiying.Present and Future of Left Bundle Branch Area Pacing[J].Advances in Cardiovascular Diseases,2020,(3):462.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.006]
[5]陈天欢 李小明.心力衰竭患者心脏再同步化治疗最新进展[J].心血管病学进展,2020,(12):1290.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.016]
CHEN Tianhuan,LI Xiaoming.Cardiac Resynchronization Therapy in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(3):1290.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.016]
[6]陈益帆 周秀娟.希氏束起搏在心力衰竭患者中的临床应用进展[J].心血管病学进展,2021,(1):64.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
CHEN Yifan,ZHOU Xiujuan.Clinical Application of His Bundle Pacing in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):64.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[7]苗旺 张楠 王睿.希浦系统起搏在心脏再同步化治疗中的应用[J].心血管病学进展,2021,(8):707.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.009]
MIAO Wang ZHANG Nan WANG Rui.Application of His-Purkinje System Pacing in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2021,(3):707.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.009]
[8]汪汉 蔡琳邓晓奇 李锦 童琳 刘汉雄.双心室起搏模式下心力衰竭患者的心脏研究[J].心血管病学进展,2022,(4):380.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.022]
WANG Han,CAI lin,DENG Xiaoqi,et al.Cardiac Electromechanical Coupling in Patients with Heart Failure under Biventricular Pacing Mode[J].Advances in Cardiovascular Diseases,2022,(3):380.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.022]
[9]李瑞瑞 李学斌.起搏诱导性心肌病临床研究进展[J].心血管病学进展,2022,(2):133.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.010]
LI RuiruiLI Xuebin.Progress of Clinical Research on Pacing-Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(3):133.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.010]
[10]陈铳铳 周秀娟.左束支起搏治疗心力衰竭的研究进展[J].心血管病学进展,2022,(2):137.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.011]
CHEN Chongchong,ZHOU Xiujuan.Left Bundle Branch Pacing in the Treatment of Heart Failure[J].Advances in Cardiovascular Diseases,2022,(3):137.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.011]
[11]吴文坚 王齐齐 周冬辰 胡晓晟 刘忠.生物标志物预测心脏再同步化治疗反应性的研究进展[J].心血管病学进展,2021,(10):869.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.002]
WU WenjianWANG QiqiZHOU DongchenHU XiaoshengLIU Zhong.Biomarkers for Predicting Response to Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2021,(3):869.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.002]